MILWAUKEE, WI, November 19, 2024 (EZ Newswire) -- As biopharmaceutical sponsors face increasing challenges in securing investigative sites for their clinical trials, the ability to reduce ...
In the early 2000s, Paul Harris, a research informatics faculty member and bioengineer at Vanderbilt University Medical Center, noticed a pressing problem. While working with research teams, he found ...
For years, one of the biggest barriers to effectively implementing artificial intelligence (AI) into clinical trial data management has been a lack of trust in its capabilities. Although this concern ...
Automation consistently comes up to help tackle today’s complexity in clinical trials, but there are different ideas of what it is and where it is useful. We asked several leaders in trial operations, ...
A pattern quickly emerged after speaking to clinical data executives at events in Basel, New York, London, and Copenhagen. Although thousands of miles apart, the focus on simplifying and standardizing ...
Lakshmi Priya Darshini Pulavarthi is a skilled Clinical Data Management professional with over a decade of experience managing data from Phase I-III clinical trials. With a strong educational ...
CAMPBELL, Calif.--(BUSINESS WIRE)--Saama Technologies, LLC. (“Saama”) today announced a multi-year agreement with Merck, known as MSD outside the United States and Canada, to build and operationalize ...
Clinical trials have become increasingly expensive, time-consuming, and complex, leading sponsors to look for more efficient ways to conduct their business. Risk-based quality management (RBQM) is ...
Thought LeadersAoife Hayes, Kevin O'Regan & Julie ScanlonClinical Trials Assitant, Operations Manager & Quality Assurance ManagerAtlantia Clinical Trials Food clinical trials may not be as familiar to ...
Veeva Systems' stock price has surged by 21% since June 2023, driven by their data analytics and AI capabilities in the healthcare industry. The company estimates a $20 billion total addressable ...
In today’s globalized pharma environment, technical and supply chain challenges in the clinical trial process create ripple effects felt by stakeholders across regions and functions. This has created ...
Mergers and acquisitions (M&As) are highly prevalent in the healthcare industry—a trend that will likely continue into the foreseeable future. The first half of 2024 saw 31 announced hospital M&As, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results